234 related articles for article (PubMed ID: 16865065)
21. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1.
Mallet Y; Nouwen J; Lecomte-Houcke M; Desaulty A
Laryngoscope; 2003 Feb; 113(2):328-31. PubMed ID: 12567091
[TBL] [Abstract][Full Text] [Related]
22. A study on epidermal proliferation ability in cholesteatoma.
Tanaka Y; Shiwa M; Kojima H; Miyazaki H; Kamide Y; Moriyama H
Laryngoscope; 1998 Apr; 108(4 Pt 1):537-42. PubMed ID: 9546266
[TBL] [Abstract][Full Text] [Related]
23. The oncoprotein, gankyrin, is up-regulated in middle ear cholesteatoma.
Kim KH; Lim HJ; Kim YJ; Kim SW; Kim YS; Tian C; Park K; Park TJ; Choung YH
Acta Otolaryngol; 2014 Mar; 134(3):238-43. PubMed ID: 24460153
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of Ki-67 expression in recurrent cases of cholesteatoma].
Sanli A; Tezer I; Paksoy M; Aydin S; Hardal U; Ozdemir NB
Kulak Burun Bogaz Ihtis Derg; 2007; 17(2):65-9. PubMed ID: 17527055
[TBL] [Abstract][Full Text] [Related]
25. [Role of epithelial cell proliferation and apoptosis in human middle ear cholesteatoma].
Zhu W; Huang D; Jing L; Zhang F
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Jul; 15(7):291-2, 295. PubMed ID: 12541781
[TBL] [Abstract][Full Text] [Related]
26. Proliferation activity and apoptosis in granulation tissue and cholesteatoma in middle ear reoperations.
Durko M; Kaczmarczyk D
Folia Morphol (Warsz); 2004 Feb; 63(1):119-21. PubMed ID: 15039916
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
Woo HJ; Park JC; Bae CH; Song SY; Lee HM; Kim YD
Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
[TBL] [Abstract][Full Text] [Related]
28. PCNA, Ki-67 and hTERT in residual benign meningiomas.
Maes L; Kalala JP; Cornelissen M; De Ridder L
In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
[TBL] [Abstract][Full Text] [Related]
30. The combination of the Zenon labeling technique and microscopic image analysis to study cell populations in normal and psoriatic epidermis.
van Duijnhoven MW; van de Kerkhof PC; Pasch MC; Muys L; van Erp PE
J Cutan Pathol; 2005 Mar; 32(3):212-9. PubMed ID: 15701083
[TBL] [Abstract][Full Text] [Related]
31. Chromosomal imbalances are associated with increased proliferation and might contribute to bone destruction in cholesteatoma.
Ecsedi S; Rákosy Z; Vízkeleti L; Juhász A; Sziklai I; Adány R; Balázs M
Otolaryngol Head Neck Surg; 2008 Nov; 139(5):635-40. PubMed ID: 18984256
[TBL] [Abstract][Full Text] [Related]
32. Reversibility of experimental cholesteatoma epithelium using Mongolian gerbils.
Park K; Choung YH; Chun YM; Lee JS; Hong SP
Acta Otolaryngol; 2005 May; 125(5):540-6. PubMed ID: 16092548
[TBL] [Abstract][Full Text] [Related]
33. Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis.
Huisman MA; De Heer E; Grote JJ
Acta Otolaryngol; 2003 Apr; 123(3):377-82. PubMed ID: 12737294
[TBL] [Abstract][Full Text] [Related]
34. Photoaging-associated changes in epidermal proliferative cell fractions in vivo.
Kwon OS; Yoo HG; Han JH; Lee SR; Chung JH; Eun HC
Arch Dermatol Res; 2008 Jan; 300(1):47-52. PubMed ID: 17968567
[TBL] [Abstract][Full Text] [Related]
35. [The expression of Ras protein in human middle ear cholesteatoma].
Xu Y; Jin K; Dong W
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
[TBL] [Abstract][Full Text] [Related]
36. Role of Langerhans cells, Ki-67 protein and apoptosis in acquired cholesteatoma: prospective clinical study.
Akdogan V; Yilmaz I; Canpolat T; Ozluoglu LN
J Laryngol Otol; 2013 Mar; 127(3):252-9. PubMed ID: 23331470
[TBL] [Abstract][Full Text] [Related]
37. [Immunohistochemical detection of c-myc proto-oncogene products in middle ear cholesteatoma].
Holly A; Sittinger M; Bujía J
Laryngorhinootologie; 1995 Jun; 74(6):348-51. PubMed ID: 7662077
[TBL] [Abstract][Full Text] [Related]
38. Antigen expression of epithelial markers, collagen IV and Ki67 in middle ear cholesteatoma. An immunohistochemical Study.
Ergün S; Zheng X; Carlsöö B
Acta Otolaryngol; 1994 May; 114(3):295-302. PubMed ID: 7521107
[TBL] [Abstract][Full Text] [Related]
39. Elevated level of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatomas.
Juhász A; Sziklai I; Rákosy Z; Ecsedi S; Adány R; Balázs M
Otol Neurotol; 2009 Jun; 30(4):559-65. PubMed ID: 19395987
[TBL] [Abstract][Full Text] [Related]
40. Canine aural cholesteatoma: a histological and immunohistochemical study.
Banco B; Grieco V; Di Giancamillo M; Greci V; Travetti O; Martino P; Mortellaro CM; Giudice C
Vet J; 2014 Jun; 200(3):440-5. PubMed ID: 24775276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]